CN112458748A - 一种儿科病员服专用织物及其制备方法 - Google Patents
一种儿科病员服专用织物及其制备方法 Download PDFInfo
- Publication number
- CN112458748A CN112458748A CN202011351232.3A CN202011351232A CN112458748A CN 112458748 A CN112458748 A CN 112458748A CN 202011351232 A CN202011351232 A CN 202011351232A CN 112458748 A CN112458748 A CN 112458748A
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- fabric
- pediatric patient
- antiviral
- special
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 93
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 100
- 229920000728 polyester Polymers 0.000 claims abstract description 63
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims abstract description 56
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 52
- 239000000835 fiber Substances 0.000 claims abstract description 49
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000002156 mixing Methods 0.000 claims abstract description 37
- 229920000742 Cotton Polymers 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 36
- 229910003472 fullerene Inorganic materials 0.000 claims abstract description 32
- 239000002131 composite material Substances 0.000 claims abstract description 30
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 23
- -1 polyhexamethylene guanidine hydrochloride Polymers 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004332 silver Substances 0.000 claims abstract description 11
- 229910052709 silver Inorganic materials 0.000 claims abstract description 11
- 239000002356 single layer Substances 0.000 claims abstract description 11
- 239000010410 layer Substances 0.000 claims abstract description 10
- 238000009941 weaving Methods 0.000 claims abstract description 9
- 238000002074 melt spinning Methods 0.000 claims abstract description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 23
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 19
- 239000003242 anti bacterial agent Substances 0.000 claims description 18
- 239000003443 antiviral agent Substances 0.000 claims description 18
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 18
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002135 nanosheet Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 10
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 9
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 8
- 238000005286 illumination Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000035699 permeability Effects 0.000 abstract description 7
- 238000013329 compounding Methods 0.000 abstract description 3
- 238000007598 dipping method Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 229910021607 Silver chloride Inorganic materials 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 5
- 238000011056 performance test Methods 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 229920002413 Polyhexanide Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001699 photocatalysis Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011941 photocatalyst Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
- D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
- D06M11/46—Oxides or hydroxides of elements of Groups 4 or 14 of the Periodic Table; Titanates; Zirconates; Stannates; Plumbates
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/253—Formation of filaments, threads, or the like with a non-circular cross section; Spinnerette packs therefor
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/103—Agents inhibiting growth of microorganisms
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
- D01F6/92—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/02—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements ultrasonic or sonic; Corona discharge
- D06M10/025—Corona discharge or low temperature plasma
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/73—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with carbon or compounds thereof
- D06M11/74—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with carbon or compounds thereof with carbon or graphite; with carbides; with graphitic acids or their salts
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/83—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with metals; with metal-generating compounds, e.g. metal carbonyls; Reduction of metal compounds on textiles
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
- D06M2101/04—Vegetal fibres
- D06M2101/06—Vegetal fibres cellulosic
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/50—Modified hand or grip properties; Softening compositions
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
- D10B2201/01—Natural vegetable fibres
- D10B2201/02—Cotton
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/04—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyesters, e.g. polyethylene terephthalate [PET]
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/13—Physical properties anti-allergenic or anti-bacterial
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Woven Fabrics (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
本发明提供了一种儿科病员服专用织物及其制备方法。所述儿科病员服专用织物为由抗菌抗病毒棉纱和导湿抗菌涤纶纱线经过混纺织造得到的单层织物或者双层织物。所述抗菌抗病毒棉纱为由载银富勒烯衍生物/二氧化钛复合材料通过浸渍和浸轧工艺与棉纱复合而成;所述导湿抗菌涤纶纱线为由聚六亚甲基单胍盐酸盐与聚酯纤维母粒进行共混造粒和熔融纺丝而成的截面异形结构的聚酯纤维进行低温等离子体预处理和纤维成纱处理制备而成。本发明制备的儿科病员服专用织物在具备优异亲水性能和导湿性能的同时,还具备优异的抗菌和抗病毒性能。
Description
技术领域
本发明涉及纺织织物制备技术领域,尤其涉及一种儿科病员服专用织物及其制备方法。
背景技术
儿科病员服,是在医院住院的儿童病员穿的服装,由医院统一发放。但是,儿童的免疫力较为低下,医院又是各类病患人员集中的场所,病患身上携带着各种各样的细菌和病菌,容易附着到儿童病员穿着的病员服上,因此极易造成交叉感染,甚至造成病毒和细菌的双感染,给儿科病员的健康带来巨大的威胁。因此,有必要研究具备抗菌抗病毒防护能力的病员服,能够对医院环境所带来的细菌和病毒等有害物质起到过滤隔离作用,使细菌、病毒和各种有害的物质等不能进入儿童体内。而且,儿童的皮肤通常比较敏感且容易出汗,因此通常要求病员服具备良好的亲水性能和热湿舒适性能。
申请号为CN200310103149.4的发明专利公开了一种超双疏性杀菌防病毒织物及其制法和用于医用病员服。所述的织物材料是将超双疏织物涂层与杀菌消毒涂层有机的结合在织物表面和/或织物中。在织物的一面为超双疏织物涂层,另一面为杀菌消毒织物涂层;或织物的两面均为杀菌消毒织物涂层,在织物一面的杀菌消毒织物涂层外为超双疏织物涂层。用该织物制备医院的病员服装或防护用具,使病员服装及防护用具具有高效灭菌抗病毒及阻断病菌扩散途径的功能。但是,该织物的亲水性能和热湿舒适性能不佳,且抗菌和抗病毒性能并不能满足实际应用的需求。
有鉴于此,有必要设计一种改进的儿科病员服专用织物及其制备方法,以解决上述问题。
发明内容
本发明的目的在于提供一种儿科病员服专用织物及其制备方法。
为实现上述发明目的,本发明提供了一种儿科病员服专用织物的制备方法,包括如下步骤:
S1,水溶性多羟基富勒烯衍生物的制备:按预定比例,将间氯过氧苯甲酸和富勒烯一同加入到溶剂中,得到混合溶液,在70~90℃下,水浴加热回流搅拌处理4~8h后,离心过滤、洗涤烘干处理,得到氧化富勒烯;在45~55℃下,将所述氧化富勒烯置于浓度为25~35%的双氧水中搅拌处理1~2h,进行水解反应,然后,将反应后的溶液进行分离、真空干燥处理,得到水溶性多羟基富勒烯衍生物;
S2,复合抗菌抗病毒剂的制备:按预定比例,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银加入到乙二醇中,搅拌超声处理,得到共混液;在所述共混液中加入聚乙二醇并搅拌均匀后,再缓慢均匀滴加氯化钠/乙二醇混合溶液;在250~350w的光照下照射3~10min后,将反应后的溶液进行沉淀离心、洗涤干燥处理,得到载银富勒烯衍生物/二氧化钛复合材料,即为复合抗菌抗病毒剂;
S3,将预定量的所述复合抗菌抗病毒剂溶于水中,得到预定浓度的抗菌抗病毒液,将棉纱浸渍于所述抗菌抗病毒液中,在60~70℃下不断搅拌处理5~15min,再进行浸轧处理和烘干处理,得到抗菌抗病毒的棉纱;
S4,将聚六亚甲基单胍盐酸盐真空干燥后,再粉碎处理得到聚六亚甲基单胍盐酸盐粉末;将所述聚六亚甲基单胍盐酸盐粉末以预定比例与干燥预处理后的聚酯纤维母粒混合均匀,在250~260℃下共混造粒,制得聚酯纤维共混母粒;将所述聚酯纤维共混母粒进行熔融纺丝,得到截面为异形结构的抗菌聚酯纤维;再对所述抗菌聚酯纤维进行低温等离子体预处理和纤维成纱处理,得到导湿抗菌涤纶纱线;
S5,将步骤S3所述的抗菌抗病毒棉纱和步骤S4所述的导湿抗菌涤纶纱线进行混纺织造和后整理,得到儿科病员服专用织物。
作为本发明的进一步改进,在步骤S1中,所述间氯过氧苯甲酸和富勒烯的质量比例为(8~15):1。
作为本发明的进一步改进,在步骤S2中,所述二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银的添加比例为(8~12):(4~6):(0.2~1.0)。
作为本发明的进一步改进,在步骤S3所述抗菌抗病毒液中,所述复合抗菌抗病毒剂的浓度为10~30mg/L。
作为本发明的进一步改进,在步骤S4中,所述聚六亚甲基单胍盐酸盐粉末与所述聚酯纤维母粒的质量比例为(0.5~3.5):100。
作为本发明的进一步改进,在步骤S4中,所述抗菌聚酯纤维的截面为十字形、Y字形、双十字型、H字形中的一种或多种组合。
作为本发明的进一步改进,在步骤S5中,所述抗菌抗病毒棉纱和所述导湿抗菌涤纶纱线的混纺质量比例为(70~80):(20~30)。
作为本发明的进一步改进,在步骤S5中,所述儿科病员服专用织物为单层织物、双层织物中的一种。
作为本发明的进一步改进,在步骤S3中,所述浸轧处理采用二浸二轧工艺;所述浸轧处理中,轧液保持率大于80%。
为实现上述发明目的,本发明还提供了一种由上述制备方法制备得到的儿科病员服专用织物,其为由抗菌抗病毒棉纱和导湿抗菌涤纶纱线经过混纺织造得到的单层织物或者双层织物。
本发明的有益效果是:
1、本发明提供的儿科病员服专用织物的制备方法,采用先将富勒烯进行氧化得到氧化富勒烯,再用双氧水进行二次氧化的方式,得到水溶性多羟基富勒烯衍生物。即,在一次氧化得到氧化富勒烯的基础上,利用双氧水中的羟基自由基将氧化富勒烯进行二次氧化,形成羟基数量更多、水溶性能更加优异的多羟基富勒醇,该工艺绿色无污染、不需要引进其它离子、后处理方便,且对富勒烯的改性过程便捷高效。
2、本发明提供的儿科病员服专用织物的制备方法,通过共沉定-光照射诱导联合的方式,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银进行复合,制备出具备壳核结构且具有优异光化学性能和抗菌抗病毒性能的复合材料,其机理在于:
1)富勒醇与二维二氧化钛纳米片复合后,其并未改变宿主二氧化钛的性质与结构,二氧化钛仍保留其优异的光催化性能。Ag/AgCl异质结构由于具备表面等离子体的共振特性,使得其可见光区域内表现出很强的光吸收效果。而水溶性多羟基富勒烯衍生物(富勒醇)上具有很多共轭电子对,能够作为优异的支撑载体,并在聚乙二醇的辅助粘结作用下,将Ag材料包覆在内,形成稳定的富勒醇@Ag材料的核壳结构,可以有效防止AgCl在光照条件下被氧化,由此增强复合材料的光催化剂性能和降低复合材料的光腐蚀效果。同时,该富勒醇@Ag材料的核壳结构均匀分布于二维二氧化钛纳米片的片层表面。水溶性多羟基富勒烯衍生物、AgCl和Ag的协同作用可提高复合材料在可见光区域的吸收强度,协同增加复合材料宿主二维二氧化钛纳米片的光催化活性,由此,该复合材料在光照条件下能够产生出更多的羟基自由基,并与细菌等微生物的细胞成分发生反应,从而达到有效抗菌的功能;同时,病毒也能够被具备强氧化能力的羟基自由基氧化灭活,实现优异抗病毒性能。
2)该复合材料中的Ag和AgCl作为银系无机抗菌剂,具有其广谱高效的抗菌效果,具有生物安全,对细菌、真菌等多种微生物有强烈杀灭作用,使得其抗菌性能优异;同时,银系无机抗菌剂还能够高效抑制细胞外病毒DNA的形成,有效阻止病毒与宿主细胞相结合,显示出优异的抗病毒性能。同时,在水溶性多羟基富勒烯衍生物的包覆下,能够有效防止Ag材料氧化变色失效。
3、本发明提供的儿科病员服专用织物的制备方法,将载银富勒烯衍生物/二氧化钛复合材料与棉纱进行浸渍复合后,再采用二浸二轧处理,使得载银富勒烯衍生物/二氧化钛复合材料能够紧密牢固地负载在棉纱上,通过富勒醇上的多羟基特性改善了该复合材料的亲水性能和与棉纱纤维之间的结合性能,实现与棉纱纤维之间更高效紧密的界面结合能力。并且,由于富勒烯衍生物的水溶性多羟基的特性,使得改性处理后的棉纱的亲水性能并没有显著降低,即,其仍然具备优异的亲水性能和吸湿性能;同时,还显著提高了棉纱在光照条件下的抗菌抗病毒性能。
4、本发明提供的儿科病员服专用织物的制备方法,采用聚六亚甲基单胍盐酸盐和聚酯纤维母粒的共混体系,来制备出相容性良好且异性截面结构的聚酯纤维,该聚酯纤维通过非浸出式抗菌剂的方式来进行杀菌,在聚酯中加入少量的聚六亚甲基单胍盐酸盐能够使改性后的聚酯纤维获得优异且长效的抗菌效果。且通过异形截面结构的设计和低温等离子体处理,使得抗菌聚酯纤维具备良好的导湿性能和良好的亲水性能,能够进一步显著提升涤纶纱线的热湿舒适度和导湿性能。
5、本发明提供的儿科病员服专用织物的制备方法,将抗菌抗病毒棉纱和导湿抗菌涤纶纱线进行混纺织造,结合两种的优点,使得制备的单层织物或者双层织物在具备优异亲水性能和导湿性能的同时,还具备优异的抗菌和抗病毒性能;且棉纱的亲水性能和涤纶的导湿排汗性能两者相互协同作用,使得该织物具备优异的热湿舒适性。本发明提供的儿科病员服专用织物的回潮率达到6.12%;透湿量达到4311.3g/(m2 .d)。该儿科病员服专用织物对大肠杆菌和金黄色葡萄球菌的抑菌率均达到99.99%以上。经过50次水洗后,其抑菌率仍然达到92%以上。同时,该儿科病员服专用织物的抗病毒活性值达到3以上,对甲型H1N1、H3N2流感病毒的抗病毒活性率达到99.97%。
附图说明
图1为本发明提供的儿科病员服专用织物的制备方法的流程示意图。
具体实施方式
为了使本发明的目的、技术方案和优点更加清楚,下面具体实施例对本发明进行详细描述。
在此,还需要说明的是,为了避免因不必要的细节而模糊了本发明,在附图中仅仅示出了与本发明的方案密切相关的结构和/或处理步骤,而省略了与本发明关系不大的其他细节。
另外,还需要说明的是,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
请参阅图1所示,本发明提供了一种儿科病员服专用织物的制备方法,包括如下步骤:
S1,水溶性多羟基富勒烯衍生物的制备:按预定比例,将间氯过氧苯甲酸和富勒烯一同加入到溶剂中,得到混合溶液,在70~90℃下,水浴加热回流搅拌处理4~8h后,离心过滤、洗涤烘干处理,得到氧化富勒烯;在45~55℃下,将所述氧化富勒烯置于浓度为25~35%的双氧水中搅拌处理1~2h,进行水解反应,然后,将反应后的溶液进行分离、真空干燥处理,得到水溶性多羟基富勒烯衍生物;
S2,复合抗菌抗病毒剂的制备:按预定比例,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银加入到乙二醇中,搅拌超声处理,得到共混液;在所述共混液中加入聚乙二醇并搅拌均匀后,再缓慢均匀滴加氯化钠/乙二醇混合溶液;在250~350w的光照下照射3~10min后,将反应后的溶液进行沉淀离心、洗涤干燥处理,得到载银富勒烯衍生物/二氧化钛复合材料,即为复合抗菌抗病毒剂;
S3,将预定量的所述复合抗菌抗病毒剂溶于水中,得到预定浓度的抗菌抗病毒液,将棉纱浸渍于所述抗菌抗病毒液中,在60~70℃下不断搅拌处理5~15min,再进行浸轧处理和烘干处理,得到抗菌抗病毒的棉纱;
S4,将聚六亚甲基单胍盐酸盐真空干燥后,再粉碎处理得到聚六亚甲基单胍盐酸盐粉末;将所述聚六亚甲基单胍盐酸盐粉末以预定比例与干燥预处理后的聚酯纤维母粒混合均匀,在250~260℃下共混造粒,制得聚酯纤维共混母粒;将所述聚酯纤维共混母粒进行熔融纺丝,得到截面为异形结构的抗菌聚酯纤维;再对所述抗菌聚酯纤维进行低温等离子体预处理和纤维成纱处理,得到导湿抗菌涤纶纱线;
S5,将步骤S3所述的抗菌抗病毒棉纱和步骤S4所述的导湿抗菌涤纶纱线进行混纺织造和后整理,得到儿科病员服专用织物。
优选的,在步骤S1中,所述间氯过氧苯甲酸和富勒烯的质量比例为(8~15):1。
优选的,在步骤S2中,所述二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银的添加比例为(8~12):(4~6):(0.2~1.0)。
优选的,在步骤S3所述抗菌抗病毒液中,所述复合抗菌抗病毒剂的浓度为10~30mg/L。
优选的,在步骤S4中,所述聚六亚甲基单胍盐酸盐粉末与所述聚酯纤维母粒的质量比例为(0.5~3.5):100。
优选的,在步骤S4中,所述抗菌聚酯纤维的截面为十字形、Y字形、双十字型、H字形中的一种或多种组合。
优选的,在步骤S5中,所述抗菌抗病毒棉纱和所述导湿抗菌涤纶纱线的混纺质量比例为(70~80):(20~30)。
优选的,在步骤S5中,所述儿科病员服专用织物为单层织物、双层织物中的一种。
优选的,在步骤S3中,所述浸轧处理采用二浸二轧工艺;所述浸轧处理中,轧液保持率大于80%。
实施例1
本实施例1提供了一种儿科病员服专用织物的制备方法,包括如下步骤:
S1,水溶性多羟基富勒烯衍生物的制备:将1.0g间氯过氧苯甲酸和0.1g富勒烯一同加入到有机溶剂中,得到混合溶液,在85℃下,水浴加热回流搅拌处理6h后,离心过滤、洗涤烘干处理,得到氧化富勒烯;然后,在50℃下,将所述氧化富勒烯置于浓度为30%的双氧水中不断搅拌处理1h,进行水解反应,然后,将反应后的溶液进行分离、真空干燥处理,得到水溶性多羟基富勒烯衍生物;
S2,复合抗菌抗病毒剂的制备:按5g:1g:0.1g的质量比例,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银加入到乙二醇中,搅拌超声处理,得到共混液;在所述共混液中加入1g聚乙二醇并搅拌均匀后,再缓慢均匀滴加氯化钠/乙二醇混合溶液(氯化钠含0.03g);在300w的氙灯下照射7min后,将反应后的溶液进行沉淀离心、洗涤后,在60℃下真空干燥24h,得到载银富勒烯衍生物/二氧化钛复合材料,即为复合抗菌抗病毒剂;
S3,将预定量的所述复合抗菌抗病毒剂溶于水中,得到浓度为20mg/L的抗菌抗病毒悬浮液,将棉纱浸渍于所述抗菌抗病毒悬浮液中,在65℃下不断搅拌处理10min,再进行二浸二轧工艺,所述浸轧处理中,轧液保持率大于80%;最后,烘干处理,得到抗菌抗病毒的棉纱;
S4,将聚六亚甲基单胍盐酸盐真空干燥后,再粉碎处理得到聚六亚甲基单胍盐酸盐粉末;将所述聚六亚甲基单胍盐酸盐粉末以2.0:100的质量比例与干燥预处理后的聚酯纤维母粒混合均匀,在255℃下共混造粒,制得聚酯纤维共混母粒;将所述聚酯纤维共混母粒进行熔融纺丝,得到截面为Y字形结构的抗菌聚酯纤维;再对所述抗菌聚酯纤维进行低温等离子体预处理(功率为80w,处理时间为100s)和纤维成纱处理,得到导湿抗菌涤纶纱线;
S5,将步骤S3所述的抗菌抗病毒棉纱和步骤S4所述的导湿抗菌涤纶纱线按照质量比例为70:30进行混纺织造和后整理,得到具备优异抗菌抗病毒和导湿性能的单层织物,即为儿科病员服专用织物。
在光照条件下,经过测试,实施例1制备的儿科病员服专用织物对大肠杆菌和金黄色葡萄球菌的抑菌率均达到99.9%以上。经过50次水洗后,其抑菌率仍然达到92%以上。同时,经过抗病毒性能测试,该儿科病员服专用织物的抗病毒活性值达到3.03,对甲型H1N1、H3N2流感病毒的抗病毒活性率达到99.91%。
经过织物性能测试,该儿科病员服专用织物的回潮率达到5.37%;透湿量达到4185.9g/(m2 .d)。表明其具备优异的亲水性能和导湿性能。织物的透湿性越好,织物的吸湿排汗能力越强。
实施例2
本实施例2提供了一种儿科病员服专用织物的制备方法,包括如下步骤:
S1,水溶性多羟基富勒烯衍生物的制备:将1.0g间氯过氧苯甲酸和0.1g富勒烯一同加入到有机溶剂中,得到混合溶液,在85℃下,水浴加热回流搅拌处理6h后,离心过滤、洗涤烘干处理,得到氧化富勒烯;然后,在50℃下,将所述氧化富勒烯置于浓度为30%的双氧水中不断搅拌处理1h,进行水解反应,然后,将反应后的溶液进行分离、真空干燥处理,得到水溶性多羟基富勒烯衍生物;
S2,复合抗菌抗病毒剂的制备:按5g:2g:0.2g的质量比例,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银加入到乙二醇中,搅拌超声处理,得到共混液;在所述共混液中加入1g聚乙二醇并搅拌均匀后,再缓慢均匀滴加氯化钠/乙二醇混合溶液(氯化钠含0.05g);在300w的氙灯下照射10min后,将反应后的溶液进行沉淀离心、洗涤后,在60℃下真空干燥24h,得到载银富勒烯衍生物/二氧化钛复合材料,即为复合抗菌抗病毒剂;
S3,将预定量的所述复合抗菌抗病毒剂溶于水中,得到浓度为15mg/L的抗菌抗病毒悬浮液,将棉纱浸渍于所述抗菌抗病毒悬浮液中,在65℃下不断搅拌处理10min,再进行二浸二轧工艺,所述浸轧处理中,轧液保持率大于80%;最后,烘干处理,得到抗菌抗病毒的棉纱;
S4,将聚六亚甲基单胍盐酸盐真空干燥后,再粉碎处理得到聚六亚甲基单胍盐酸盐粉末;将所述聚六亚甲基单胍盐酸盐粉末以2.5:100的质量比例与干燥预处理后的聚酯纤维母粒混合均匀,在260℃下共混造粒,制得聚酯纤维共混母粒;将所述聚酯纤维共混母粒进行熔融纺丝,得到截面为Y字形结构的抗菌聚酯纤维;再对所述抗菌聚酯纤维进行低温等离子体预处理(功率为80w,处理时间为120s)和纤维成纱处理,得到导湿抗菌涤纶纱线;
S5,将步骤S3所述的抗菌抗病毒棉纱和步骤S4所述的导湿抗菌涤纶纱线按照质量比例为80:20进行混纺织造和后整理,得到具备优异抗菌抗病毒和导湿性能的单层织物,即为儿科病员服专用织物。
在光照条件下,经过测试,实施例1制备的儿科病员服专用织物对大肠杆菌和金黄色葡萄球菌的抑菌率均达到99.99%以上。同时,经过抗病毒性能测试,该儿科病员服专用织物的抗病毒活性值达到3以上,对甲型H1N1、H3N2流感病毒的抗病毒活性率达到99.97%。
经过织物性能测试,该儿科病员服专用织物的回潮率达到6.12%;透湿量达到4311.3g/(m2.d)。
综上所述,本发明提供了一种儿科病员服专用织物及其制备方法。所述儿科病员服专用织物为由抗菌抗病毒棉纱和导湿抗菌涤纶纱线经过混纺织造得到的单层织物或者双层织物。所述抗菌抗病毒棉纱为由载银富勒烯衍生物/二氧化钛复合材料通过浸渍和浸轧工艺与棉纱复合而成;所述导湿抗菌涤纶纱线为由聚六亚甲基单胍盐酸盐与聚酯纤维母粒进行共混造粒和熔融纺丝而成的截面异形结构的聚酯纤维进行低温等离子体预处理和纤维成纱处理制备而成。本发明制备的儿科病员服专用织物在具备优异亲水性能和导湿性能的同时,还具备优异的抗菌和抗病毒性能。
以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围。
Claims (10)
1.一种儿科病员服专用织物的制备方法,其特征在于:包括如下步骤:
S1,水溶性多羟基富勒烯衍生物的制备:按预定比例,将间氯过氧苯甲酸和富勒烯一同加入到溶剂中,得到混合溶液,在70~90℃下,水浴加热回流搅拌处理4~8h后,离心过滤、洗涤烘干处理,得到氧化富勒烯;在45~55℃下,将所述氧化富勒烯置于浓度为25~35%的双氧水中搅拌1~2h,进行水解反应,然后,将反应后的溶液进行分离、真空干燥处理,得到水溶性多羟基富勒烯衍生物;
S2,复合抗菌抗病毒剂的制备:按预定比例,将二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银加入到乙二醇中,搅拌超声处理,得到共混液;在所述共混液中加入预定量的聚乙二醇并搅拌均匀后,再缓慢均匀滴加氯化钠/乙二醇混合溶液;在250~350w的光照下照射3~10min后,将反应后的溶液进行沉淀离心、洗涤干燥处理,得到载银富勒烯衍生物/二氧化钛复合材料,即为复合抗菌抗病毒剂;
S3,将预定量的所述复合抗菌抗病毒剂溶于水中,得到预定浓度的抗菌抗病毒液,将棉纱浸渍于所述抗菌抗病毒液中,在60~70℃下不断搅拌处理5~15min,再进行浸轧处理和烘干处理,得到抗菌抗病毒棉纱;
S4,将聚六亚甲基单胍盐酸盐真空干燥后,再粉碎处理得到聚六亚甲基单胍盐酸盐粉末;将所述聚六亚甲基单胍盐酸盐粉末以预定比例与干燥预处理后的聚酯纤维母粒混合均匀,在250~260℃下共混造粒,制得聚酯纤维共混母粒;将所述聚酯纤维共混母粒进行熔融纺丝,得到截面为异形结构的抗菌聚酯纤维;再对所述抗菌聚酯纤维进行低温等离子体预处理和纤维成纱处理,得到导湿抗菌涤纶纱线;
S5,将步骤S3所述的抗菌抗病毒棉纱和步骤S4所述的导湿抗菌涤纶纱线进行混纺织造和后整理,得到儿科病员服专用织物。
2.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S1中,所述间氯过氧苯甲酸和富勒烯的质量比例为(8~15):1。
3.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S2中,所述二维二氧化钛纳米片、水溶性多羟基富勒烯衍生物和硝酸银的添加比例为(8~12):(4~6):(0.2~1.0)。
4.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S3所述抗菌抗病毒液中,所述复合抗菌抗病毒剂的浓度为10~30mg/L。
5.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S4中,所述聚六亚甲基单胍盐酸盐粉末与所述聚酯纤维母粒的质量比例为(0.5~3.5):100。
6.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S4中,所述抗菌聚酯纤维的截面为十字形、Y字形、双十字型、H字形中的一种或多种组合。
7.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S5中,所述抗菌抗病毒棉纱和所述导湿抗菌涤纶纱线的混纺质量比例为(70~80):(20~30)。
8.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S5中,所述儿科病员服专用织物为单层织物、双层织物中的一种。
9.根据权利要求1所述的一种儿科病员服专用织物的制备方法,其特征在于:在步骤S3中,所述浸轧处理采用二浸二轧工艺;所述浸轧处理中,轧液保持率大于80%。
10.一种由权利要求1至9中任一项权利要求所述的一种儿科病员服专用织物的制备方法制备得到的儿科病员服专用织物,其特征在于:所述儿科病员服专用织物为由抗菌抗病毒棉纱和导湿抗菌涤纶纱线经过混纺织造得到的单层织物或者双层织物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011351232.3A CN112458748A (zh) | 2020-11-26 | 2020-11-26 | 一种儿科病员服专用织物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011351232.3A CN112458748A (zh) | 2020-11-26 | 2020-11-26 | 一种儿科病员服专用织物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112458748A true CN112458748A (zh) | 2021-03-09 |
Family
ID=74808832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011351232.3A Withdrawn CN112458748A (zh) | 2020-11-26 | 2020-11-26 | 一种儿科病员服专用织物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112458748A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604933A (zh) * | 2021-06-28 | 2021-11-05 | 苏州耀晨新材料有限公司 | 一种单向导湿亲肤梭织复用医护材料的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102583303A (zh) * | 2012-02-24 | 2012-07-18 | 中国科学院化学研究所 | 一种制备高水溶性富勒醇的方法 |
CN106435917A (zh) * | 2016-12-07 | 2017-02-22 | 江南大学 | 一种具有抗菌、防渗透功能的涤棉复合面料及其制备方法 |
CN111424420A (zh) * | 2020-03-24 | 2020-07-17 | 同曦集团有限公司 | 一种主动广谱持久抗菌抗病毒医用防护服、纺织物及其制备方法 |
CN111549533A (zh) * | 2020-06-29 | 2020-08-18 | 浙江流庆纺织有限公司 | 高密涤锦复合纤维织物用抗病毒抗菌整理溶液及整理工艺 |
-
2020
- 2020-11-26 CN CN202011351232.3A patent/CN112458748A/zh not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102583303A (zh) * | 2012-02-24 | 2012-07-18 | 中国科学院化学研究所 | 一种制备高水溶性富勒醇的方法 |
CN106435917A (zh) * | 2016-12-07 | 2017-02-22 | 江南大学 | 一种具有抗菌、防渗透功能的涤棉复合面料及其制备方法 |
CN111424420A (zh) * | 2020-03-24 | 2020-07-17 | 同曦集团有限公司 | 一种主动广谱持久抗菌抗病毒医用防护服、纺织物及其制备方法 |
CN111549533A (zh) * | 2020-06-29 | 2020-08-18 | 浙江流庆纺织有限公司 | 高密涤锦复合纤维织物用抗病毒抗菌整理溶液及整理工艺 |
Non-Patent Citations (1)
Title |
---|
樊争科、刘琳、孙凯飞: "抗菌涤纶混纺多功能织物的开发", 《棉纺织技术》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604933A (zh) * | 2021-06-28 | 2021-11-05 | 苏州耀晨新材料有限公司 | 一种单向导湿亲肤梭织复用医护材料的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11134686B2 (en) | Disinfectant composition for textile and related substrates, and method of treating a substrate to provide disinfecting antibacterial, antiviral and antifungal, wash durable, optionally enhanced with multifunctional properties | |
Andra et al. | Emerging nanomaterials for antibacterial textile fabrication | |
EP2730621B1 (en) | Antiviral resin member | |
Dastjerdi et al. | A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties | |
AU2001244512B2 (en) | Methods and fabrics for combating nosocomial infections | |
CN101716359B (zh) | 一种杀菌消毒材料及其应用 | |
EP3253819B1 (en) | Antimicrobial material comprising synergistic combinations of metal oxides | |
CN103436982B (zh) | 一种改性涤纶纤维及其制备方法 | |
CN105506984A (zh) | 用天然生物材料对纺织品进行抗菌、抗病毒整理的方法 | |
US20020177828A1 (en) | Absorbent materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces, and methods for preparation | |
WO2000025940A1 (en) | Light-activated antimicrobial and antiviral materials | |
AU2001244512A1 (en) | Methods and fabrics for combating nosocomial infections | |
CN101225604A (zh) | 一种含抗菌肽的涂层织物及其制备方法 | |
CN111418607B (zh) | 一种复合纳米银抗病毒剂及其制备方法和应用 | |
CN112458748A (zh) | 一种儿科病员服专用织物及其制备方法 | |
CN103590135B (zh) | 一种多用途涤纶纤维及其制备方法 | |
Mondal et al. | Metal and metal oxides nanoparticles in healthcare and medical textiles | |
Bahtiyari et al. | Antimicrobial textiles for the healthcare system | |
Selvasudha et al. | Smart antimicrobial textiles for healthcare professionals and individuals | |
KR20050118713A (ko) | 병원 및 수술실용 일회용 종이-계 제품 | |
CN1359305A (zh) | 具有杀病毒和抗微生物活性的药物纤维及其制品 | |
CN216139549U (zh) | 一种抗菌抗病毒面料及医用防护服 | |
CN115139599B (zh) | 一种可重复使用的医用防护织物及灭菌方法 | |
EP3957202A1 (en) | Method for producing anti-viral fiber product, and anti-viral mask obtained using same | |
WO2024131999A2 (zh) | 一种长效耐洗涤抗菌消臭纺织品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210309 |
|
WW01 | Invention patent application withdrawn after publication |